FdaApplication
NDA 215358
Identifiers
- fda_app_no: NDA215358
Properties
| Property | Value |
|---|---|
| applicant_name | NOVARTIS PHARMACEUTICALS CORP |
| application_type | NDA |
| approval_date | 2021-10-29 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SCEMBLIX | ASCIMINIB HYDROCHLORIDE | EQ 20MG BASE | TABLET;ORAL |
| SCEMBLIX | ASCIMINIB HYDROCHLORIDE | EQ 100MG BASE | TABLET;ORAL |
| SCEMBLIX | ASCIMINIB HYDROCHLORIDE | EQ 40MG BASE | TABLET;ORAL |
3 products